- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0040171

Aspia Parenteral Private Limited
About Aspia Parenteral Private Limited
Data last updated:
Aspia Parenteral Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2018PTC111467. Its GSTIN is 09AARCA7001R1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹8.7 Cr and a paid-up capital of ₹8.7 Cr. It is led by directors including Dimpal Singh and Praveen Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Lucknow, Uttar Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.83 Cr. For the same year it recorded a net profit of ₹1.53 Lakh (net margin 0.2%) and EBITDA of ₹1.59 Cr (EBITDA margin 16.2%).
As per MCA filings, the company has open charges of ₹15.54 Cr on record. Court records list 5 cases involving the company, including 5 filed against it; 3 cases are pending.
Aspia Parenteral Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0040171).
Company details
Recognitions & Rankings of Aspia Parenteral
Contact details
Aspia Parenteral Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKh. No. 552 Anaura Kalan, Papnamau Chinhat, Lucknow, Uttar Pradesh, India – 226028
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aspia Parenteral Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aspia Parenteral is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aspia Parenteral Private Limited, buy the company report.
Financials of Aspia Parenteral Private Limited
FY 2024 filings availableAspia Parenteral Private Limited reported revenue of ₹9.83 Cr for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aspia Parenteral Private Limited, buy the company report.
Board of directors of Aspia Parenteral Private Limited
Aspia Parenteral has 7 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dimpal Singh Also directs: Satakshi Contractors Private Limited | Director | 07 Feb 2025 | 1 Years 8 Months | Current |
| Praveen Singh | Director | 20 Apr 2021 | 5 Years 6 Months | Current |
| Mukesh Kumar | Director | 24 Oct 2019 | 7 Years 0 Months | Current |
| Mamta | Director | 19 Dec 2018 | 7 Years 10 Months | Current |
| Surajman Vishvakarma Also directs: Ipsol Healthcare Private Limited | Director | 08 Dec 2023 | 2 Years 10 Months | Current |
| Geeta Singh | Director | 24 Apr 2025 | 1 Years 6 Months | Current |
Peer comparison
Aspia Parenteral Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shri Vari Pharma Private Limited | ₹9.87 Cr (FY 2024) | 45.0% | Ponneri, Tamil Nadu, India | |||
| Seelam Laboratories Private Limited | ₹9.84 Cr (FY 2024) | 100.0% | Hyderabad, Telangana, India | |||
| Aspia Parenteral Private Limitedthis company | ₹9.83 Cr (FY 2024) | ₹1.53 Lakh | 0.2% | Lucknow, Uttar Pradesh, India | ||
| Lepro Pharma Compass OPC Private Limited | ₹9.79 Cr (FY 2024) | 17.0% | New Delhi, Delhi, India |
To see the full peer comparison of Aspia Parenteral Private Limited, buy the company report.
Auditor
Aspia Parenteral Private Limited is audited by AWANEENDRA KUMAR DUBEY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AWANEENDRA KUMAR DUBEY | FY 2023 | 523311 |
Shareholding
The shareholding of Aspia Parenteral Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aspia Parenteral Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Feb 2022 | 100540675 | State Bank of India | ₹15.54 Cr | Open |
To see the full charge records of Aspia Parenteral Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Aspia Parenteral Private Limited has 5 court cases on record: 5 filed against it. 3 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 3 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Bokaro, Jharkhand | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by an individual | Pending |
| District court, GANDHINAGAR, Gujarat | Criminal complaint | Filed against the company by Patel Rakeshkumar Harjivandas Prop. of Hari Om Chemicals | Pending |
| District court, Nainital, Uttarakhand | Commercial suit | Filed against the company by M/S Rays Packaging Products | Disposed |
| District court, GANDHINAGAR, Gujarat | Court case (CR EN) | Filed against the company by Patel Rakeshkumar Harjivandas - M/S Hariom Camicals | Disposed |
To see the full case history of Aspia Parenteral Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aspia Parenteral Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aspia Parenteral has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AARCA7001R1Z1 | Uttar Pradesh | Active | 01 Jan 2019 |
To see the full GST registrations and return filing status of Aspia Parenteral Private Limited, buy the company report.
Recent activity
Aspia Parenteral Private Limited has 10 board changes on record since 2018: 7 appointments and 3 cessations. The latest: Dharmendra Yadav ceased to be Director on 02 May 2025.
3 earlier events are in the company report.
Frequently asked questions
Aspia Parenteral is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 December 2018 (8+ years old) and is registered under CIN U51909UP2018PTC111467.
Aspia Parenteral has 7 current directors:
- Dimpal Singh - Director
- Praveen Singh - Director
- Mukesh Kumar - Director
- Mamta - Director
- Surajman Vishvakarma - Director
- Geeta Singh - Director
- Vinod Kumar Singh - Director
The latest financial statements of Aspia Parenteral on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Aspia Parenteral is 09AARCA7001R1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aspia Parenteral is U51909UP2018PTC111467. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aspia Parenteral has 5 court cases on record: 5 filed against it. 3 are pending.
Aspia Parenteral was incorporated on 19 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Aspia Parenteral by revenue are Shri Vari Pharma Private Limited, Seelam Laboratories Private Limited, Lepro Pharma Compass OPC Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dharmendra Yadav ceased to be Director on 02 May 2025. Geeta Singh was appointed as Director on 24 Apr 2025. Dimpal Singh was appointed as Director on 07 Feb 2025. Aspia Parenteral has 10 board changes on record in total.
Yes, Aspia Parenteral is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0040171).
The registered office of Aspia Parenteral is at Kh. No. 552 Anaura Kalan, Papnamau Chinhat, Lucknow, Uttar Pradesh, India – 226028.